First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort studyManuel Rubio‐Rivas, Xavier Corbella, Melany Pestaña-Fernández et al.|Clinical Rheumatology|2017Cited by 47
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 RegistryCrhistian‐Mario Oblitas, Pedro Jesús Esteve Atiénzar, Lucía Barrera-López et al.|Scientific Reports|2025Cited by 0